Explorer les evidences

9 600 000 deathsIn 2017, there were 9.6 million cancer deaths worldwide.

Camerouncancer (non précisé)observé 2017publié 2019JAMA oncologyeurope_pmcdocument de 25 observationsDOI 10.1001/jamaoncol.2019.2996

64 %Among unclassifiable protease (PR) sequences from HIV-1-infected, drug-naïve Cameroonians, 64% had dual and triple PI resistance-associated substitutions.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

12,4 %Twenty-one patients (12.4%) were found with HCV RNA.

Camerounhépatite Cpublié 2009HIV MedicineOpenAlexdocument de 5 observations

63 %In 2010, 63% of deaths from cardiovascular diseases, chronic kidney disease, and diabetes were attributable to the combined effect of high blood pressure, high BMI, high glucose, and high cholesterol.

Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0

97,1 odds_ratioPeople with type 2 diabetes had greater odds of having an outpatient visit to any clinician (OR 97.1 [95% CI: 41.6–226.2]) compared with people without diabetes.

Cameroundiabète de type 2publié 2017BMC health services researcheurope_pmcdocument de 7 observationsDOI 10.1186/s12913-017-2197-0

64,7 %Among 198 subjects with diabetic retinopathy, 128 (64.7%) had non-proliferative diabetic retinopathy in both eyes.

Camerounnon-proliferative diabetic retinopathyobservé November 2007 to December 2008publié 2010Sante (Montrouge, France)europe_pmcdocument de 8 observations

5 %A 5% decrease or more was observed for diurnal mean arterial pressure in type 2 diabetes patients receiving ginger add-on therapy.

Cameroundiabète de type 2publié 2022Annales de cardiologie et d'angeiologieeurope_pmcdocument de 6 observations

4,17 %La fréquence de la neuropathie polyneuropathique au Cameroun était de 4,17 % en 2013.

Camerounneuropathie périphériqueobservé 2013HAL · Unilimdocument de 747 observations

61,9 %Crude, three-year retention was 61.9% (95% CI: 58.8–64.9) at hospitals.

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

Triglyceride concentrations were significantly higher in HHV8 antibody-positive than HHV8 antibody-negative participants after excluding HHV8 DNA-positive participants.

Cameroundiabète (non précisé) · HHV8publié 2018Journal of diabeteseurope_pmcdocument de 10 observations

15 %In 2010, high BMI was responsible for about 15% of deaths from cardiovascular diseases, chronic kidney disease, and diabetes.

Cameroundiabète (non précisé) · high BMI · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0

50,4 per_100000The median annual incidence of epilepsy is estimated to be 50.4 per 100,000.

CamerounépilepsieHAL · Unilimdocument de 53 observations

13,2 %The estimated lifetime risk of stroke in low-SDI countries was 13.2%.

CamerounAVCobservé 2016publié 2018The New England journal of medicineeurope_pmcdocument de 12 observations

42,9 %Sensitivity for the detection of moderate nonproliferative diabetic retinopathy using the smartphone-based retinal camera was 42.9%.

Camerounmoderate nonproliferative diabetic retinopathypublié 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument de 16 observations

13,2 %Cameroon accounted for 13.2% (35/265) of infections among imported malaria cases.

CamerounpaludismeHAL · Unilimdocument de 123 observations

4,8 %In Pouma HD, prevalence of SCE ranged between 3.0 and 5.0% in one community (Pouma Centre administratif: 4.8%).

CamerounSCEHAL · Unilimdocument de 53 observations

7,3 pmol/lPlasma atrial natriuretic peptide was increased in the hypertensive patients (7.3 +/- 1.1 pmol l-1) compared to normotensive diabetic patients (4.7 +/- 1.1 pmol l-1) and normal control subjects (4.0 +/- 0.2 pmol l-1).

Cameroundiabète de type 2publié 1989Diabetic medicine : a journal of the British Diabetic Associationeurope_pmcdocument de 4 observations

20,1 %Global age-standardised prevalence of raised blood pressure was 20.1% in women in 2015.

Camerounraised blood pressureobservé 2015publié 2017Lancet (London, England)europe_pmcdocument de 7 observations

13,1 %From 2009 to 2012, the prevalence of overweight and obesity in men increased from 13.1% to 20.9%.

Camerounobésitéobservé 2009 to 2012publié 2017BMC public healtheurope_pmcdocument de 9 observations

64 %Males had an overall malaria prevalence of 64% (843/1317).

CamerounpaludismeHAL · Unilimdocument de 106 observations

89 specimensPhylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 89 were subtype A.

CamerounVIH/sidapublié 2000AIDS Research and Human RetrovirusesOpenAlexdocument de 7 observations

109 countriesIn 2016, smoking remained among the leading five risk factors for DALYs in 109 countries.

Camerounsmokingobservé 2016publié 2017Lancet (London, England)europe_pmcdocument de 16 observationsDOI 10.1016/s0140-6736(17)32366-8

81,1 %At day 3, 77 out of 95 participants (81.1%) on hydroxychloroquine-azithromycin were asymptomatic.

CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838

29,5 %In Bertoua, the Anopheles gambiae (s.l.) population consisted of 29.5% Anopheles coluzzii.

CamerounpaludismeHAL · Unilimdocument de 89 observations

200 per_100000In 2010, age-standardised death rates from cardiovascular diseases, chronic kidney disease, and diabetes attributable to the combined effects of high blood pressure, high BMI, high glucose, and high cholesterol were less than 200 deaths per 100 000 for men in the Netherlands.

Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0